Virios Therapeutics, Inc. (NASDAQ:VIRI – Get Free Report) rose 0.7% during mid-day trading on Monday . The stock traded as high as $1.4272 and last traded at $1.38. Approximately 73,869 shares changed hands during mid-day trading, a decline of 93% from the average session volume of 1,049,645 shares. The stock had previously closed at $1.37.
Virios Therapeutics Stock Up 0.7%
The stock has a market capitalization of $26.58 million, a PE ratio of -5.11 and a beta of 1.58. The stock has a fifty day moving average of $1.59 and a 200-day moving average of $2.28.
About Virios Therapeutics
Virios Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for fibrotic diseases. The company leverages its proprietary small-molecule platform to identify and advance compounds designed to modulate key pathways involved in scar formation and tissue repair. By concentrating on conditions with high unmet medical need, Virios aims to improve patient outcomes through more effective and safer treatment options.
The company’s lead development candidate, VTI-1002, is an oral small molecule inhibitor in clinical trials for the prevention and treatment of hypertrophic scars and keloids.
Further Reading
- Five stocks we like better than Virios Therapeutics
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for Virios Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virios Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
